CSI - Congressional Special Interests
Abstract
In FY13, the Defense Health Program funded Congressional Special Interest (CSI) directed research. The strategy for the FY13 Congressionally-directed research is to stimulate innovative research through a competitive, peer-reviewed research program, and focused medical research at intramural and extramural research sites. Specific peer-reviewed research efforts include the following: Amyotrophic Lateral Sclerosis (ALS) (degenerative neuronal disorder that causes muscle weakness and atrophy throughout the body), Autism, Bone Marrow Failure Disease, Ovarian Cancer, Multiple Sclerosis, Cancer, Lung Cancer, Orthopedic Research, Spinal Cord Research, Vision, Traumatic Brain Injury and Psychological Health (TBI/PH), Breast Cancer, Prostate Cancer, Gulf War Illness, Alcohol and Substance Use Disorders, Medical Research, Alzheimer Research, Joint Warfighter Medical Research, Global HIV/AIDS Prevention, Tuberous Sclerosis Complex (rare multi-system genetic disease that causes growth of non-malignant tumors in the brain and other vital organs), Duchenne Muscular Dystrophy (gene mutation affecting boys that causes muscle degeneration and eventual death), and the Walter Reed National Military Medical Comprehensive Cancer Center. Because of the CSI annual structure, out-year funding is not programmed.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2015
- Source ID
- 300A_0603115HP_2_0130_PB_2015